Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
B 88.16 2.29% 1.97
HZNP closed down 5.3 percent on Thursday, March 4, 2021, on 1.15 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical HZNP trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 1.82%
MACD Bearish Signal Line Cross Bearish 1.82%
Multiple of Ten Bearish Other 1.82%
Multiple of Ten Bullish Other -3.57%
Upper Bollinger Band Touch Strength -3.57%
Up 3 Days in a Row Strength -7.12%
Upper Bollinger Band Touch Strength -7.12%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.52%
Narrow Range Bar Range Contraction -4.52%
NR7 Range Contraction -4.52%
Older End-of-Day Signals for HZNP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 20 DMA about 1 hour ago
60 Minute Opening Range Breakout about 2 hours ago
20 DMA Resistance about 2 hours ago
Up 3% about 2 hours ago
Up 2% about 2 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Horizon Pharma, Inc. Description

Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Pain Autoimmune Diseases Gastrointestinal Inflammatory Disease Symptoms Inflammatory Diseases Rheumatoid Arthritis Asthma Osteoarthritis Pulmonary Disease Ulcer Chronic Obstructive Pulmonary Disease Deerfield Arthritis Rheumatology Ibuprofen

Is HZNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 96.52
52 Week Low 23.81
Average Volume 2,093,256
200-Day Moving Average 70.69
50-Day Moving Average 80.71
20-Day Moving Average 88.65
10-Day Moving Average 89.75
Average True Range 4.42
ADX 27.51
+DI 27.92
-DI 20.48
Chandelier Exit (Long, 3 ATRs ) 83.25
Chandelier Exit (Short, 3 ATRs ) 93.57
Upper Bollinger Band 94.98
Lower Bollinger Band 82.31
Percent B (%b) 0.31
BandWidth 14.29
MACD Line 2.77
MACD Signal Line 3.11
MACD Histogram -0.3424
Fundamentals Value
Market Cap 19.02 Billion
Num Shares 221 Million
EPS 3.61
Price-to-Earnings (P/E) Ratio 23.86
Price-to-Sales 8.49
Price-to-Book 3.98
PEG Ratio 1.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.14
Resistance 3 (R3) 94.82 92.86 92.82
Resistance 2 (R2) 92.86 90.83 92.52 92.37
Resistance 1 (R1) 89.52 89.58 88.54 88.84 91.93
Pivot Point 87.56 87.56 87.07 87.22 87.56
Support 1 (S1) 84.22 85.53 83.24 83.54 80.45
Support 2 (S2) 82.26 84.28 81.92 80.01
Support 3 (S3) 78.92 82.26 79.57
Support 4 (S4) 78.24